Dr. Meghan Riddle, MD
Claim this profileButler Hospital
Studies Alzheimer's Disease
Studies Mild Cognitive Impairment
6 reported clinical trials
13 drugs studied
Area of expertise
1Alzheimer's Disease
ApoE positive
ApoE negative
2Mild Cognitive Impairment
ApoE positive
ApoE negative
Affiliated Hospitals
Clinical Trials Meghan Riddle, MD is currently running
Donanemab
for Early Alzheimer's Disease
This trial is testing different doses of donanemab, a drug aimed at helping people with early Alzheimer's disease. Donanemab has shown rapid reduction of brain amyloid in early Alzheimer's disease. The study will look at how often and how severely participants experience a side effect involving brain swelling. Researchers also want to find out which patient characteristics might predict this side effect.
Recruiting1 award Phase 3
CT1812
for Early Alzheimer's Disease
This is a multicenter randomized, double-blind, placebo-controlled Phase 2 study designed to evaluate the efficacy, safety, and tolerability of two doses of CT1812 compared to placebo in participants diagnosed with early Alzheimer's disease.
Recruiting0 awards Phase 2
More about Meghan Riddle, MD
Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Meghan Riddle, MD has experience with
- Placebo
- Emtricitabine
- Donanemab
- Aducanumab
- MK-6240
- NAV4694
Breakdown of trials Meghan Riddle, MD has run
Alzheimer's Disease
Mild Cognitive Impairment
Dementia
Cognitive Impairment
Nervous System Disorders
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Meghan Riddle, MD specialize in?
Meghan Riddle, MD focuses on Alzheimer's Disease and Mild Cognitive Impairment. In particular, much of their work with Alzheimer's Disease has involved ApoE positive patients, or patients who are ApoE negative.
Is Meghan Riddle, MD currently recruiting for clinical trials?
Yes, Meghan Riddle, MD is currently recruiting for 5 clinical trials in Providence Rhode Island. If you're interested in participating, you should apply.
Are there any treatments that Meghan Riddle, MD has studied deeply?
Yes, Meghan Riddle, MD has studied treatments such as Placebo, Emtricitabine, Donanemab.
What is the best way to schedule an appointment with Meghan Riddle, MD?
Apply for one of the trials that Meghan Riddle, MD is conducting.
What is the office address of Meghan Riddle, MD?
The office of Meghan Riddle, MD is located at: Butler Hospital, Providence, Rhode Island 02906 United States. This is the address for their practice at the Butler Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.